- Home
- UG vs LUCD Comparison
UG vs LUCD Comparison
Compare UG & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UG
- LUCD
- Stock Information
- Founded
- UG 1942
- LUCD 2018
- Country
- UG United States
- LUCD United States
- Employees
- UG N/A
- LUCD N/A
- Industry
- UG Package Goods/Cosmetics
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UG Consumer Discretionary
- LUCD Health Care
- Exchange
- UG Nasdaq
- LUCD Nasdaq
- Market Cap
- UG 45.5M
- LUCD 49.0M
- IPO Year
- UG N/A
- LUCD 2021
- Fundamental
- Price
- UG $10.72
- LUCD $0.84
- Analyst Decision
- UG
- LUCD Strong Buy
- Analyst Count
- UG 0
- LUCD 4
- Target Price
- UG N/A
- LUCD $3.63
- AVG Volume (30 Days)
- UG 10.2K
- LUCD 277.7K
- Earning Date
- UG 11-08-2024
- LUCD 11-13-2024
- Dividend Yield
- UG 5.60%
- LUCD N/A
- EPS Growth
- UG 38.11
- LUCD N/A
- EPS
- UG 0.76
- LUCD N/A
- Revenue
- UG $12,312,275.00
- LUCD $4,189,000.00
- Revenue This Year
- UG N/A
- LUCD $91.72
- Revenue Next Year
- UG N/A
- LUCD $139.38
- P/E Ratio
- UG $14.14
- LUCD N/A
- Revenue Growth
- UG 11.51
- LUCD 179.27
- 52 Week Low
- UG $7.02
- LUCD $0.63
- 52 Week High
- UG $16.25
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- UG 63.40
- LUCD 51.29
- Support Level
- UG $10.20
- LUCD $0.80
- Resistance Level
- UG $10.91
- LUCD $0.88
- Average True Range (ATR)
- UG 0.24
- LUCD 0.05
- MACD
- UG 0.15
- LUCD 0.01
- Stochastic Oscillator
- UG 86.63
- LUCD 55.57
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.